Backed by partners at Pfizer, eFFECTOR brings its VC total to $150M as PhII cancer trial looms
With a big assist from its Big Pharma collaborator Pfizer, San Diego-based eFFECTOR Therapeutics has now added a $38.5 million round to pay for a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
